Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AMRN [NASD]
Amarin Corporation plc
Index- P/E- EPS (ttm)-1.05 Insider Own3.87% Shs Outstand172.43M Perf Week-9.71%
Market Cap272.44M Forward P/E- EPS next Y-0.34 Insider Trans- Shs Float149.51M Perf Month-12.22%
Income-166.20M PEG- EPS next Q-0.19 Inst Own32.00% Short Float18.56% Perf Quarter-30.09%
Sales26.40M P/S10.32 EPS this Y16.90% Inst Trans-0.13% Short Ratio8.00 Perf Half Y-69.44%
Book/sh-0.20 P/B- EPS next Y46.00% ROA-64.40% Target Price2.43 Perf Year-76.20%
Cash/sh1.11 P/C1.42 EPS next 5Y- ROE322.90% 52W Range1.36 - 7.98 Perf YTD-19.80%
Dividend- P/FCF- EPS past 5Y-4.20% ROI-83.50% 52W High-80.20% Beta0.71
Dividend %- Quick Ratio5.30 Sales past 5Y- Gross Margin54.90% 52W Low16.18% ATR0.10
Employees185 Current Ratio5.90 Sales Q/Q- Oper. Margin- RSI (14)35.82 Volatility6.92% 5.28%
OptionableYes Debt/Eq- EPS Q/Q-28.60% Profit Margin- Rel Volume0.27 Prev Close1.60
ShortableYes LT Debt/Eq- EarningsFeb 27 AMC Payout- Avg Volume3.47M Price1.58
Recom2.60 SMA20-10.41% SMA50-11.65% SMA200-53.52% Volume937,324 Change-1.25%
01-Apr-14Reiterated MKM Partners Neutral $1.50 → $2
24-Feb-14Reiterated MKM Partners Neutral $2.50 → $1.75
16-Jan-14Downgrade MKM Partners Buy → Neutral $2.50
08-Nov-13Reiterated MKM Partners Buy $5 → $2.50
30-Oct-13Initiated FBR Capital Mkt Perform $2
17-Oct-13Reiterated MKM Partners Buy $9 → $5
17-Oct-13Downgrade Canaccord Genuity Buy → Hold $10 → $3
17-Oct-13Downgrade Aegis Capital Buy → Hold
20-Mar-13Initiated Chardan Capital Markets Hold $8.50
10-Dec-12Reiterated Aegis Capital Buy $25 → $35
07-Dec-12Reiterated Aegis Capital Buy $25 → $35
12-Jul-11Initiated MKM Partners Buy $23
25-Apr-11Reiterated Wedbush Outperform $12 → $18
18-Apr-11Reiterated Canaccord Genuity Buy $11 → $18
29-Dec-10Reiterated Wedbush Outperform $7 → $10
20-Jul-10Initiated Wedbush Outperform $5
03-Feb-09Initiated Rodman & Renshaw Mkt Outperform $3.50
06-Nov-08Initiated Rodman & Renshaw Mkt Outperform $3.50
15-Apr-14 09:44AM  The Supreme Court Will Decide the Fate of a Blockbuster at Motley Fool
10-Apr-14 02:30PM  More Trouble Looming for Amarin Corporation? at Motley Fool
06-Apr-14 12:13PM  Partner Signed! Is Amarin's Turnaround Beginning? at Motley Fool
01-Apr-14 03:21PM  Amarin Takes Step 1, Of A Million, To Right Its Ship at Seeking Alpha +6.08%
02:31PM  Can This Drive Growth for Amarin Corporation plc? at Motley Fool
12:21PM  Story Stocks from Briefing.com Briefing.com
07:25AM  Story Stocks from Briefing.com Briefing.com
12:53AM  Amarin: How The Co-Promotion Agreement With Kowa Affects Required Sales Targets at Seeking Alpha
31-Mar-14 07:09PM  On The Fly: After Hours Movers at theflyonthewall.com
04:41PM  AMARIN CORP PLC\UK Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements EDGAR Online
04:30PM  Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa(R) (icosapent ethyl) Capsules GlobeNewswire
28-Mar-14 06:00AM  3 Biotech Stocks Under $10 to Trade for Breakouts at TheStreet
21-Mar-14 02:31PM  Better Chance of Making a Comeback: Amarin plc or VIVUS, Inc.? at Motley Fool
07:00AM  Biotech Stock Mailbag: Amarin, Cytrx, Sangamo and 'Story Stocks' at TheStreet
14-Mar-14 04:46PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
07-Mar-14 01:04PM  AMARIN CORP PLC\UK Financials EDGAR Online Financials
06-Mar-14 05:01PM  AMARIN CORP PLC\UK Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibi EDGAR Online
04-Mar-14 05:35PM  If You Can't Make Your Drug a Blockbuster, Sue Your Competitor at Motley Fool
05:35PM  If You Can't Make Your Drug a Blockbuster, Sue Your Competitor
06:14AM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
28-Feb-14 02:17PM  Can Amarin Corporation PLC Stop Burning Cash? at Motley Fool
02:17PM  Can Amarin Corporation PLC Stop Burning Cash?
27-Feb-14 10:20PM  Amarin Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
10:20PM  Amarin Management Discusses Q4 2013 Results - Earnings Call Transcript
08:30PM  Amarin Sues FDA Over Exclusivity for Fish Oil Pill at Bloomberg
08:30PM  Amarin Sues FDA Over Exclusivity for Fish Oil Pill
04:07PM  AMARIN CORP PLC\UK Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
04:01PM  Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations GlobeNewswire
07:07AM  Q4 2013 Amarin Corporation PLC Earnings Release - After Market Close CCBN
26-Feb-14 02:16PM  Amarin Is Likely Now A Vortex Where Your Money Will Go To Die at Seeking Alpha
25-Feb-14 02:54PM  What Now For Amarin? at Seeking Alpha
09:31AM  Two Years Less Exclusivity Is the Least of Amarin's Issues at Motley Fool
24-Feb-14 04:20PM  Amarin's Vascepa Gets 3-Year Exclusivity Zacks
07:59AM  Amarin Loses Bid for Vascepa 5-Year Market Exclusivity at TheStreet
06:00AM  Amarin to Report Fourth Quarter and Year-End 2013 Results and Host Conference Call on February 27, 2014 GlobeNewswire
21-Feb-14 10:05PM  Amarin Given 3-Year Exclusivity for Vascepa at Motley Fool
04:12PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events EDGAR Online
04:01PM  Amarin Announces FDA Award of Three-Year Exclusivity for Vascepa(R) (icosapent ethyl) Capsules GlobeNewswire
17-Feb-14 03:37PM  3 Biotech Stocks to Avoid: Amarin, Dendreon, and Prosensa at Motley Fool
14-Feb-14 03:21PM  Amarin Corporation Plc's Rocky Road at Motley Fool
06-Feb-14 06:30AM  Amarin to Present at the 2014 Leerink Global Healthcare Conference GlobeNewswire -5.46%
04-Feb-14 06:00AM  Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales GlobeNewswire +6.63%
25-Jan-14 12:15PM  The Best- And Worst-Performing Biotech Stocks, Jan. 17 to Jan. 24 at Forbes
12:15PM  The Best- And Worst-Performing Biotech Stocks, Jan. 17 to Jan. 24
24-Jan-14 05:17PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:17PM  AMARIN CORP PLC\UK Files SEC form 8-K, Other Events, Financial Statements and Exhibits
22-Jan-14 11:02PM  Why Amarin Corporation PLC Lost Big, and What's Next for Its Fish Oil Drug at Motley Fool
11:02PM  Why Amarin Corporation PLC Lost Big, and What's Next for Its Fish Oil Drug
04:10PM  Amarin Tumbles after DMEP Decision Zacks
04:10PM  Amarin Tumbles after DMEP Decision
03:04PM  Amarin Is Down but Not Out at Motley Fool
03:04PM  Amarin Is Down but Not Out
02:08PM  Correction: Amarin-Ahead of the Bell AP
02:08PM  Correction: Amarin-Ahead of the Bell
21-Jan-14 08:35PM  Why Amarin, Walter Energy, and Skechers USA Tumbled Today at Motley Fool -23.79%
01:44PM  Why Amarin Corporation PLC Shares Were Hammered at Motley Fool
01:44PM  Why Amarin Corporation PLC Shares Were Hammered
10:10AM  FDA To Amarin: 'I Said Good Day, Sir!' at Seeking Alpha
10:10AM  FDA To Amarin: 'I Said Good Day, Sir!'
10:07AM  Story Stocks from Briefing.com Briefing.com
08:58AM  Why Amarin Corporation, CytRx Corporation, and Aegerion Pharmaceuticals Could Be the Biggest Biotech Stories of the Day at Motley Fool
08:58AM  Why Amarin Corporation, CytRx Corporation, and Aegerion Pharmaceuticals Could Be the Biggest Biotech Stories of the Day
08:15AM  Ahead of the Bell: Amarin shares take another fall AP
08:15AM  Ahead of the Bell: Amarin shares take another fall
01:00AM  Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request GlobeNewswire
01:00AM  Amarin Announces FDA Review Division Response to ANCHOR SPA Agreement Reinstatement Request
20-Jan-14 04:13PM  Amarin: Is No News Good News? at Seeking Alpha
04:13PM  Amarin: Is No News Good News?
18-Jan-14 02:32PM  Ariad Pharmaceuticals, Inc. and Amarin Corporation plc (ADR): Can These Biotechs Bounce Back in 2014? at Motley Fool
17-Jan-14 08:48PM  Handicapping Amarin's Delay at Motley Fool
16-Jan-14 02:32PM  Why Amarin Corporation PLC Shares Sank at Motley Fool -5.83%
10:35AM  Amarin downgraded by MKM Partners Briefing.com
09:24AM  Why You Should Watch Amarin Corporation plc (ADR) and Sarepta Therapeutics Inc. Today at Motley Fool
09:24AM  Why You Should Watch Amarin Corporation plc (ADR) and Sarepta Therapeutics Inc. Today
07:02AM  Amarin downgraded to Neutral from Buy at MKM Partners at theflyonthewall.com
07:02AM  Amarin downgraded to Neutral from Buy at MKM Partners
04:12AM  Amarin Delay Piques Investor Interest And Sparks Debate at Seeking Alpha
04:12AM  Amarin Delay Piques Investor Interest And Sparks Debate
15-Jan-14 06:59PM  On The Fly: After Hours Movers at theflyonthewall.com +15.94%
06:59PM  On The Fly: After Hours Movers
05:55PM  Amarin says FDA delays decision on Vascepa trial design Reuters
05:55PM  Amarin says FDA delays decision on Vascepa trial design
05:16PM  Why Chelsea Therapeutics, Datalink, and Amarin Are Today's 3 Best Stocks at Motley Fool
05:16PM  Why Chelsea Therapeutics, Datalink, and Amarin Are Today's 3 Best Stocks
04:05PM  Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed GlobeNewswire
04:05PM  Amarin Announces FDA Review Division Response on ANCHOR SPA Agreement Reinstatement Request Will Be Delayed
13-Jan-14 04:45PM  Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap at MarketWatch
04:45PM  Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap
04:01PM  Stock market live blog: Lockhart sees more tapering, Dow's loss deepens at MarketWatch
02:21PM  Stock market live blog: Lockhart sees more tapering, Dow's loss deepens at MarketWatch
01:23PM  Stock market live blog: Lockhart sees more tapering, Dow's loss deepens at MarketWatch
11:57AM  Stock market live blog: Biotechs on the move, Goldman's Kostin sees 'lofty' valuations at MarketWatch
11:15AM  Stock market live blog: Biotechs on the move, Goldman's Kostin sees 'lofty' valuations at MarketWatch
09:19AM  Intercept, Celgene on move amid J.P. Morgan event at MarketWatch
09:19AM  Intercept, Celgene on move amid J.P. Morgan event
12-Jan-14 11:35AM  Amarin Out, Intercept Pharma In at JPMorgan Healthcare Confab at TheStreet
11:35AM  Amarin Out, Intercept Pharma In at JPMorgan Healthcare Confab
11-Jan-14 08:34AM  While Amarin Continues To Go Rancid, Neptune Will Soar at Seeking Alpha
08:34AM  While Amarin Continues To Go Rancid, Neptune Will Soar
10-Jan-14 05:26PM  AMARIN CORP PLC\UK Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online
Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization therapeutic products for the treatment for cardiovascular diseases in the United States. It develops products in the areas of lipid science and therapeutic benefits of polyunsaturated fatty acids. The company markets Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. It is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.